These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15569374)
21. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Alonso M; Tamasdan C; Miller DC; Newcomb EW Mol Cancer Ther; 2003 Feb; 2(2):139-50. PubMed ID: 12589031 [TBL] [Abstract][Full Text] [Related]
22. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931 [TBL] [Abstract][Full Text] [Related]
23. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031 [TBL] [Abstract][Full Text] [Related]
24. Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines. Mayer F; Mueller S; Malenke E; Kuczyk M; Hartmann JT; Bokemeyer C Invest New Drugs; 2005 Jun; 23(3):205-11. PubMed ID: 15868376 [TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer. Chien M; Astumian M; Liebowitz D; Rinker-Schaeffer C; Stadler WM Cancer Chemother Pharmacol; 1999; 44(1):81-7. PubMed ID: 10367753 [TBL] [Abstract][Full Text] [Related]
26. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Carlson B; Lahusen T; Singh S; Loaiza-Perez A; Worland PJ; Pestell R; Albanese C; Sausville EA; Senderowicz AM Cancer Res; 1999 Sep; 59(18):4634-41. PubMed ID: 10493518 [TBL] [Abstract][Full Text] [Related]
27. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines. Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542 [TBL] [Abstract][Full Text] [Related]
28. Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating Apoptosis. Tan C; Qian X; Ge Y; Yang B; Wang F; Guan Z; Cai J Pathol Oncol Res; 2017 Apr; 23(2):323-328. PubMed ID: 27585443 [TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation. Puppo M; Pastorino S; Melillo G; Pezzolo A; Varesio L; Bosco MC Clin Cancer Res; 2004 Dec; 10(24):8704-19. PubMed ID: 15623656 [TBL] [Abstract][Full Text] [Related]
30. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells. Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309 [TBL] [Abstract][Full Text] [Related]
34. Effects of flavopiridol on critical regulation pathways of CD133high/CD44high lung cancer stem cells. Bozok Cetintas V; Acikgoz E; Yigitturk G; Demir K; Oktem G; Tezcanli Kaymaz B; Oltulu F; Aktug H Medicine (Baltimore); 2016 Oct; 95(43):e5150. PubMed ID: 27787370 [TBL] [Abstract][Full Text] [Related]
35. The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. König A; Schwartz GK; Mohammad RM; Al-Katib A; Gabrilove JL Blood; 1997 Dec; 90(11):4307-12. PubMed ID: 9373241 [TBL] [Abstract][Full Text] [Related]
36. Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos. McAleer MF; Duffy KT; Davidson WR; Kari G; Dicker AP; Rodeck U; Wickstrom E Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):546-51. PubMed ID: 16904844 [TBL] [Abstract][Full Text] [Related]
37. Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit. Jung CP; Motwani MV; Schwartz GK Clin Cancer Res; 2001 Aug; 7(8):2527-36. PubMed ID: 11489836 [TBL] [Abstract][Full Text] [Related]
38. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins. Wang D; Qin Q; Jiang QJ; Wang DF J Xray Sci Technol; 2016 Apr; 24(4):639-46. PubMed ID: 27080362 [TBL] [Abstract][Full Text] [Related]
39. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity. Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540 [TBL] [Abstract][Full Text] [Related]
40. Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells. Kim JC; Saha D; Cao Q; Choy H Radiother Oncol; 2004 May; 71(2):213-21. PubMed ID: 15110456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]